![Søren Nielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Søren Nielsen is the founder of SynAct Pharma AB, which was founded in 2012.
He currently works as a Director at ApoGlyx AB. Previously, he worked as the Chief Executive Officer at Action Pharma A.
Aktive Positionen von Søren Nielsen
| Unternehmen | Position | Beginn |
|---|---|---|
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Søren Nielsen
| Unternehmen | Position | Ende |
|---|---|---|
| SYNACT PHARMA AB | Gründer | - |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Präsident | 05.02.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
